You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 4,642,384


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,642,384
Title: Process for the preparation of derivatives of pyrrolidine and piperidine
Abstract:Processes and intermediates for the preparation of the antiarrhythmic agent 2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide.
Inventor(s): Leir; Charles M. (New Richmond, WI)
Assignee: Riker Laboratories, Inc. (St. Paul, MN)
Application Number:06/772,470
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 4,642,384

Introduction

United States Patent 4,642,384, titled "Flecainide Synthesis," is a significant patent in the field of pharmaceutical chemistry, particularly in the synthesis of flecainide, a medication used to treat certain types of irregular heartbeat. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background and Context

Flecainide is an antiarrhythmic drug used to treat various cardiac arrhythmias. The synthesis of flecainide involves several chemical steps, and the patent in question describes a specific method for its production.

Patent Overview

Publication Details

  • Patent Number: 4,642,384
  • Publication Date: Not specified in the provided sources, but typically available through patent databases.
  • Assignees: The assignees are not mentioned in the provided sources, but this information can be found in the patent document itself.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broad scope of the invention, while dependent claims narrow down the scope by adding additional limitations.

Claim Examples

  • The patent describes a method for synthesizing flecainide, which includes steps such as reacting specific compounds to form the desired product. For instance, the method might involve the isolation of flecainide acetate by filtration of the final reaction mixture to remove the catalyst, followed by evaporation[2].

Claim Scope and Coverage

The claims in this patent are crucial as they define what is protected under the patent. They typically cover the specific chemical reactions, reagents, and conditions necessary for the synthesis of flecainide.

Scope Concepts and Claim Charts

To understand the full scope of the patent, it is helpful to use tools like claim charts and scope concepts. These tools categorize the claims by overarching concepts, making it easier to analyze and compare with other patents in the same field.

Claim Coverage Matrix

A Claim Coverage Matrix, as described by patent analytics services, can help in identifying which claims are actively protecting the intellectual property related to flecainide synthesis. This matrix can highlight gaps or opportunities in the patent coverage, allowing for more strategic management of the patent portfolio[3].

Patent Landscape Analysis

Related Patents and Continuations

Understanding the patent landscape involves identifying related patents, continuations, and continuations-in-part. For example, if there are other patents related to flecainide synthesis, they might be continuations or continuations-in-part of the original patent.

Family Members and Priority Dates

Analyzing the family members of the patent, including any continuations or continuations-in-part, helps in understanding the full breadth of the patent protection. This includes examining the priority dates and the relationships between different patents in the family[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical concept in patent law that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other extensions. This concept is relevant when analyzing the validity of claims in related patents[1].

Patent Term Adjustment (PTA) and Terminal Disclaimers

The patent term can be affected by PTA, which compensates for delays during the prosecution process. However, terminal disclaimers, which are often used to overcome ODP rejections, can impact the patent term differently. Understanding these concepts is essential for managing the patent portfolio effectively[1].

Quality of Patent Examination

The quality of the patent examination process is crucial for ensuring that the granted patents are valid and enforceable. The USPTO has made efforts to improve the quality of patent examinations, including increasing the time available for certain art units to perform thorough searches[4].

Industry Impact and Market Domination

Competitive Advantage

A well-managed patent portfolio, including patents like 4,642,384, can provide a significant competitive advantage in the pharmaceutical industry. By protecting the synthesis method of a critical drug like flecainide, the patent holder can control the market and prevent competitors from using the same method.

Future Directions and Design Opportunities

Using tools like claim charts and scope concepts, companies can identify future design opportunities and potential gaps in their current coverage. This strategic approach helps in maintaining a strong patent portfolio and staying ahead in the market[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Landscape: Analyzing related patents and family members helps in understanding the full breadth of patent protection.
  • ODP and PTA: These concepts are vital for managing patent validity and term adjustments.
  • Patent Quality: Ensuring high-quality patent examinations is essential for the validity and enforceability of patents.
  • Market Impact: A well-managed patent portfolio can provide a significant competitive advantage.

Frequently Asked Questions (FAQs)

What is the significance of United States Patent 4,642,384?

This patent is significant because it describes a specific method for the synthesis of flecainide, an important antiarrhythmic drug.

How do claim charts and scope concepts help in patent analysis?

Claim charts and scope concepts help in categorizing and analyzing patent claims, making it easier to identify gaps or opportunities in the patent coverage and to determine the value of the patent claims to the company.

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA or other extensions.

How does Patent Term Adjustment (PTA) affect the patent term?

PTA compensates for delays during the prosecution process, extending the patent term. However, terminal disclaimers can impact the patent term differently and are often used to overcome ODP rejections.

Why is the quality of patent examination important?

The quality of patent examination is crucial for ensuring that the granted patents are valid and enforceable, which in turn affects the strength and value of the patent portfolio.

Cited Sources:

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. WO2002066413A1 - Flecainide synthesis - Google Patents
  3. Patent Analytics | Intellectual Property Law
  4. Intellectual Property: Patent Office Should Define Quality, Reassess ...

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,642,384

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.